Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity

References

• Krishnaswamy G., Kelley J., Yerra L., Kelly‐Smith J., Chi D. S. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 1999; 19: 91–104
   PubMed Web of Science ®Google Scholar
• Belmont H. M., Abramson S. B., Lie J. T. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. Arthritis Rheum 1996; 39: 9–22
   PubMed Web of Science ®Google Scholar
• Calamia K. T., Balabanova M. Vasculitis in systemic lupus erythematosus. Clin Dermatol 2004; 22: 148–56
   PubMedGoogle Scholar
• Cutolo M., Sulli A., Pizzorni C., Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 155–60
   PubMed Web of Science ®Google Scholar
• Cutolo M., Sulli A., Secchi M. E., Pizzorni C. [Capillaroscopy and rheumatic diseases: state of the art], in German. Z Rheumatol 2006; 65: 290–6
   PubMedGoogle Scholar
• Ingegnoli F., Zeni S., Meani L., Soldi A., Lurati A., Fantini F. Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. J Clin Rheumatol 2005; 11: 295–8
   PubMed Web of Science ®Google Scholar
• Cutolo M., Grassi W., Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003; 48: 3023–30
   PubMed Web of Science ®Google Scholar
• Nagy Z., Czirják. Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease. J Eur Acad Dermatol Venereol 2004; 18: 62–8
   PubMed Web of Science ®Google Scholar
• de Holanda Mafaldo Diógenes A., Bonfá E., Fuller R., Correia Caleiro M. T. Capillaroscopy is a dynamic process in mixed connective tissue disease. Lupus 2007; 16: 254–8
   PubMedGoogle Scholar
• Riccieri V., Spadaro A., Ceccarelli F., Scrivo R., Germano V., Valesini G. Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile. Lupus 2005; 14: 521–5
   PubMed Web of Science ®Google Scholar
• Kuryliszyn‐Moskal A. Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systemic vasculitis and microvascular capillaroscopic abnormalities. Clin Rheumatol 1998; 17: 489–95
   PubMed Web of Science ®Google Scholar
• Kuryliszyn‐Moskal A., Klimiuk P. A., Sierakowski S. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule‐1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?. Arch Immunol Ther Exp 2001; 49: 423–30
   PubMedGoogle Scholar
• Kuryliszyn‐Moskal A., Klimiuk P. A., Sierakowski S., Ciolkiewicz M. Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities. Arch Immunol Ther Exp 2007; 55: 179–85
   PubMedGoogle Scholar
• Clancy R., Marder G., Martin V., Belmont H. M., Abramson S. B., Buyon J. Circulating activated endothelial cells in systemic lupus erythematosus. Further evidence for diffuse vasculopathy. Arthritis Rheum 2001; 44: 1203–8
   PubMed Web of Science ®Google Scholar
• Hurrairah H., Ferro A. The role of endothelium in the control of vascular function. Int J Clin Pract 2004; 58: 173–83
   PubMedGoogle Scholar
• Kikuchi K., Kubo M., Kadono T., Yazawa N., Ihn H., Tamaki K. Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol 1998; 139: 1049–51
   PubMed Web of Science ®Google Scholar
• Navarro C., Candia‐Zuniga L., Silveira L. H., Ruiz V., Gaxiola M., Avila M. C., et al. Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Lupus 2002; 11: 21–4
   PubMed Web of Science ®Google Scholar
• Robak E., Woźniacka A., Sysa‐Jędrzejowska A., Stępień H., Robak T. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus. Lupus 2002; 11: 348–55
   PubMedGoogle Scholar
• Moreli S., Ferri C., Polettini E., Bellini C., Gualdi G. F., Pittoni V., et al. Plasma endothelin‐1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med 1995; 99: 255–60
   PubMedGoogle Scholar
• Nyberg F., Stephansson E. Elevated soluble E‐selectin in cutaneous lupus erythematosus. Adv Exp Med Biol 1999; 455: 153–9
   PubMedGoogle Scholar
• Haq A., El‐Ramahi K., Al‐Dalaan A., Al‐Sedairy S. T. Serum and synovial fluid concentrations of endothelin‐1 in patients with rheumatoid arthritis. J Med 1999; 3: 51–60
   Google Scholar
• Boehme M. W., Schmitt W. H., Youinou P., Stremmel W. R., Gross W. L. Clinical relevance of elevated serum thrombomodulin and soluble E‐selectin in patients with Wegener's granulomatosis and other systemic vasculitides. Am J Med 1996; 101: 387–94
   PubMedGoogle Scholar
• Kuryliszyn‐Moskal A., Klimiuk P. A., Sierakowski S., Ciolkiewicz M. A study on vascular endothelial growth factor and endothelin‐1 in patients with extra‐articular involvement of rheumatoid arthritis. Clin Rheumatol 2006; 25: 314–19
   PubMed Web of Science ®Google Scholar
• Kuryliszyn‐Moskal A., Klimiuk P. A., Sierakowski S. Soluble adhesion molecules (sVCAM‐1, sE‐selectin), vascular endothelial growth factor (VEGF) and endothelin‐1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol 2005; 24: 111–16
   PubMed Web of Science ®Google Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Gladman D. D., Ibanez D., Urowitz M. B. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288–91
   PubMed Web of Science ®Google Scholar
• Szabo N., Csiki Z., Szanto A., Danko K., Szodoray P., Zeher M. Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud's and Sjögren's syndrome and poly/dermatomyositis. Scand J Rheumatol 2008; 37: 23–9
   PubMed Web of Science ®Google Scholar
• Cutolo M., Pizzorni C., Sulli A. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al. Arthritis Rheum 2007; 56: 2102–3
   PubMedGoogle Scholar
• Pavlov‐Dolijanovic S., Damjanov N., Ostojic P., Sussic G., Stojanovic R., Gacic D., et al. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary Raynaud phenomenon: a follow‐up study of 250 patients. Pediatr Dermatol 2006; 23: 437–42
   PubMedGoogle Scholar
• Ohtsuka T. Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases. Int J Dermatol 1999; 38: 757–64
   PubMedGoogle Scholar
• Cutolo M., Sulli A., Secchi M. E., Paolino S., Pizzorni C. Nailfold capillaroscopy is useful for the diagnosis and follow‐up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?. Rheumatology 2006; 45: iv43–6
   PubMed Web of Science ®Google Scholar
• Kabasakal Y., Elvins D. M., Ring E. F. J., McHugh N. J. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996; 55: 507–12
   PubMed Web of Science ®Google Scholar
• Kuryliszyn‐Moskal A., Klimiuk P. A., Sierakowski S. Cytokines and autoantibodies in rheumatoid arthritis and connective tissue diseases: relationship to systemic vasculitis and capillaroscopic abnormalities. EFIS 2000, 14^th European Immunology Meeting, Poznań, Poland, 23–27 September 2000, A. Mackiewicz, M. Kurpisz, J. Żeromski. Monduzzi Editore, Bologna 2001; 165–71
   Google Scholar
• Dancour M. A. A., Vaz J. L. P., Bottino D. A., Bouskela E. Nailfold videocapillaroscopy in patients with systemic lupus erythematosus. Rheumatol Int 2006; 26: 633–7
   PubMedGoogle Scholar
• Bongard O., Bounameaux H., Miescher P. A., De Moerloose P. Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 1995; 4: 142–4
   PubMedGoogle Scholar
• Clavel G., Bessis N., Boissier M. C. Recent data on the role for angiogenesis in rheumatoid arthritis. Joint Bone Spine 2003; 70: 321–6
   PubMedGoogle Scholar
• Pache M., Schwarz H. A., Kaiser H. J., Wüest P., Klöti M., Dubler B., et al. Elevated plasma endothelin‐1 levels and vascular dysregulation in patients with rheumatoid arthritis. Med Sci Monit 2002; 8: CR616–19
   PubMedGoogle Scholar
• Witte T., Hartung K., Sachse C., Frickes M., Buyny S., Deicher H., et al. Thrombomodulin in systemic lupus erythematosus: association with clinical and laboratory parameters. Rheumatol Int 1999; 19: 15–18
   PubMed Web of Science ®Google Scholar
• Julkunen H., Saijonmaa O., Gronhagen‐Riska C., Teppo A. M., Fyhrqiust F. Raised plasma concentrations of endothelin‐1 in systemic lupus erythematosus. Ann Rheum Dis 1991; 5: 526–7
   Google Scholar
• El‐Gamal Y. M., Heshmat N. M., El‐Kerdany T. H., Fawzy A. F. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis. Pediatr Allergy Immunol 2004; 15: 270–7
   PubMedGoogle Scholar
• Egerer K., Feist E., Rohr U., Pruss A., Burmester G. R., Dorner T. Increased serum soluble CD14, ICAM‐1 and E‐selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000; 9: 614–21
   PubMed Web of Science ®Google Scholar
• Mrowka C., Sieberth H. G. Detection of circulating adhesion molecules ICAM‐1, VCAM‐1 and E‐selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure. Clin Nephrol 1995; 43: 288–96
   PubMed Web of Science ®Google Scholar
• Spronk P. E., Bootsma H., Huitema M. G., Limburg P. C., Kallenberg C. G. Levels of soluble VCAM‐1, soluble ICAM‐1, and soluble E‐selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long‐term prospective study. Clin Exp Immunol 1994; 97: 439–44
   PubMed Web of Science ®Google Scholar